Oleoyl-estrone is a precursor of an estrone-derived ponderostat signal

Oleoyl-estrone (OE) is a powerful anti-obesity compound that decreases food intake, decreases insulin resistance and circulating cholesterol. OE stimulates a severe loss of body fat by decreasing adipose tissue lipid synthesis and maintaining lipolysis. Therefore, the body economy loses lipid energy...

Descripción completa

Detalles Bibliográficos
Autores: Vilà Pont, Ruth, Cabot, Cristina, Villarreal, Laura, Monegal, Ana, Ayet Galcerà, Eva, Romero Romero, María del Mar, Grasa Martínez, Maria del Mar, Esteve Ràfols, Montserrat, Fernández López, José Antonio, Remesar Betlloch, Xavier, Alemany, Marià, 1946-
Tipo de recurso: artículo
Estado:Versión aceptada para publicación
Fecha de publicación:2011
País:España
Institución:Universidad de Barcelona
Repositorio:Dipòsit Digital de la UB
OAI Identifier:oai:diposit.ub.edu:2445/130564
Acceso en línea:https://hdl.handle.net/2445/130564
Access Level:acceso abierto
Palabra clave:Oleat d'estrona
Teixit adipós
Oleoyl-estrone
Adipose tissues
id ES_ee9fb06b807d3e6cd469947acbedf99f
oai_identifier_str oai:diposit.ub.edu:2445/130564
network_acronym_str ES
network_name_str España
repository_id_str
spelling Oleoyl-estrone is a precursor of an estrone-derived ponderostat signalVilà Pont, RuthCabot, CristinaVillarreal, LauraMonegal, AnaAyet Galcerà, EvaRomero Romero, María del MarGrasa Martínez, Maria del MarEsteve Ràfols, MontserratFernández López, José AntonioRemesar Betlloch, XavierAlemany, Marià, 1946-Oleat d'estronaTeixit adipósOleoyl-estroneAdipose tissuesOleoyl-estrone (OE) is a powerful anti-obesity compound that decreases food intake, decreases insulin resistance and circulating cholesterol. OE stimulates a severe loss of body fat by decreasing adipose tissue lipid synthesis and maintaining lipolysis. Therefore, the body economy loses lipid energy because energy expenditure is maintained. This study analyses the discrepancy between OE effects and the distribution of labelled OE in plasma. Estrone radioimmunoassay of organic solvent plasma extracts of rats treated with OE showed the massive presence of acyl-estrone, but. saponification did not release estrone, but containing similar unknown compound. Analysis of label distribution in plasma after oral gavages of 3H-OE showed the presence of a more hydrophilic compound than OE or any estrogen as well as 3H2O, formed from 3H-OE in the acidic stomach medium. OE was not attached toa specific transporter in plasma. Through serum HPLC analysis we found W, a labelled derivative more hydrophilic than OE or estrone. The results were confirmed using 14C-OE. HPLC-MS/MS studies showed that plasma OE levels were one order of magnitude lower than those of W. When liver cell cytosols from rats laden with 3H-OE were incubated with nuclei from untreated rats, the OE-derived label (i.e., W's) was found attached to nuclear DNA. Neither estradiol nor estrone interfered with its binding. W is a fairly hydrophilic compound of low molecular weight containing the estrone nucleus, but it is not an ester because saponification or esterases do not yield estrone as OE does. It is concluded that OE acts through its conversion to W, its active form; which binds to a nuclear receptor different from that of estrogen. The estimated W serum levels are proportional to the pharmacological OE effects in vivo. We postulate W as a new type of hormone that exerts the full range of in vivo effects thus far attributed to OE. The full identification of W is anticipated to open the way for the development of new OE-like anti-obesity drugs.Elsevier Ltd2011info:eu-repo/semantics/articleinfo:eu-repo/semantics/acceptedVersionapplication/pdfhttps://hdl.handle.net/2445/130564Articles publicats en revistes (Bioquímica i Biomedicina Molecular)reponame:Dipòsit Digital de la UBinstname:Universidad de BarcelonaInglésVersió postprint del document publicat a: https://doi.org/10.1016/j.jsbmb.2011.01.017Journal of Steroid Biochemistry and Molecular Biology, 2011, vol. 124, num. 3-5, p. 99-111https://doi.org/10.1016/j.jsbmb.2011.01.017(c) Elsevier Ltd, 2011info:eu-repo/semantics/openAccessoai:diposit.ub.edu:2445/1305642026-05-27T06:46:51Z
dc.title.none.fl_str_mv Oleoyl-estrone is a precursor of an estrone-derived ponderostat signal
title Oleoyl-estrone is a precursor of an estrone-derived ponderostat signal
spellingShingle Oleoyl-estrone is a precursor of an estrone-derived ponderostat signal
Vilà Pont, Ruth
Oleat d'estrona
Teixit adipós
Oleoyl-estrone
Adipose tissues
title_short Oleoyl-estrone is a precursor of an estrone-derived ponderostat signal
title_full Oleoyl-estrone is a precursor of an estrone-derived ponderostat signal
title_fullStr Oleoyl-estrone is a precursor of an estrone-derived ponderostat signal
title_full_unstemmed Oleoyl-estrone is a precursor of an estrone-derived ponderostat signal
title_sort Oleoyl-estrone is a precursor of an estrone-derived ponderostat signal
dc.creator.none.fl_str_mv Vilà Pont, Ruth
Cabot, Cristina
Villarreal, Laura
Monegal, Ana
Ayet Galcerà, Eva
Romero Romero, María del Mar
Grasa Martínez, Maria del Mar
Esteve Ràfols, Montserrat
Fernández López, José Antonio
Remesar Betlloch, Xavier
Alemany, Marià, 1946-
author Vilà Pont, Ruth
author_facet Vilà Pont, Ruth
Cabot, Cristina
Villarreal, Laura
Monegal, Ana
Ayet Galcerà, Eva
Romero Romero, María del Mar
Grasa Martínez, Maria del Mar
Esteve Ràfols, Montserrat
Fernández López, José Antonio
Remesar Betlloch, Xavier
Alemany, Marià, 1946-
author_role author
author2 Cabot, Cristina
Villarreal, Laura
Monegal, Ana
Ayet Galcerà, Eva
Romero Romero, María del Mar
Grasa Martínez, Maria del Mar
Esteve Ràfols, Montserrat
Fernández López, José Antonio
Remesar Betlloch, Xavier
Alemany, Marià, 1946-
author2_role author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Oleat d'estrona
Teixit adipós
Oleoyl-estrone
Adipose tissues
topic Oleat d'estrona
Teixit adipós
Oleoyl-estrone
Adipose tissues
description Oleoyl-estrone (OE) is a powerful anti-obesity compound that decreases food intake, decreases insulin resistance and circulating cholesterol. OE stimulates a severe loss of body fat by decreasing adipose tissue lipid synthesis and maintaining lipolysis. Therefore, the body economy loses lipid energy because energy expenditure is maintained. This study analyses the discrepancy between OE effects and the distribution of labelled OE in plasma. Estrone radioimmunoassay of organic solvent plasma extracts of rats treated with OE showed the massive presence of acyl-estrone, but. saponification did not release estrone, but containing similar unknown compound. Analysis of label distribution in plasma after oral gavages of 3H-OE showed the presence of a more hydrophilic compound than OE or any estrogen as well as 3H2O, formed from 3H-OE in the acidic stomach medium. OE was not attached toa specific transporter in plasma. Through serum HPLC analysis we found W, a labelled derivative more hydrophilic than OE or estrone. The results were confirmed using 14C-OE. HPLC-MS/MS studies showed that plasma OE levels were one order of magnitude lower than those of W. When liver cell cytosols from rats laden with 3H-OE were incubated with nuclei from untreated rats, the OE-derived label (i.e., W's) was found attached to nuclear DNA. Neither estradiol nor estrone interfered with its binding. W is a fairly hydrophilic compound of low molecular weight containing the estrone nucleus, but it is not an ester because saponification or esterases do not yield estrone as OE does. It is concluded that OE acts through its conversion to W, its active form; which binds to a nuclear receptor different from that of estrogen. The estimated W serum levels are proportional to the pharmacological OE effects in vivo. We postulate W as a new type of hormone that exerts the full range of in vivo effects thus far attributed to OE. The full identification of W is anticipated to open the way for the development of new OE-like anti-obesity drugs.
publishDate 2011
dc.date.none.fl_str_mv 2011
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/acceptedVersion
format article
status_str acceptedVersion
dc.identifier.none.fl_str_mv https://hdl.handle.net/2445/130564
url https://hdl.handle.net/2445/130564
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv Versió postprint del document publicat a: https://doi.org/10.1016/j.jsbmb.2011.01.017
Journal of Steroid Biochemistry and Molecular Biology, 2011, vol. 124, num. 3-5, p. 99-111
https://doi.org/10.1016/j.jsbmb.2011.01.017
dc.rights.none.fl_str_mv (c) Elsevier Ltd, 2011
info:eu-repo/semantics/openAccess
rights_invalid_str_mv (c) Elsevier Ltd, 2011
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier Ltd
publisher.none.fl_str_mv Elsevier Ltd
dc.source.none.fl_str_mv Articles publicats en revistes (Bioquímica i Biomedicina Molecular)
reponame:Dipòsit Digital de la UB
instname:Universidad de Barcelona
instname_str Universidad de Barcelona
reponame_str Dipòsit Digital de la UB
collection Dipòsit Digital de la UB
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869423738277068800
score 15,301603